Home » Posts tagged 'alan green'
Tag Archives: alan green
Alan Green talks Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES on the Vox Markets podcast
Alan Green discusses Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES with Justin Waite on the Vox Markets podcast. Interview is 14 minutes in.
Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk
Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk.
Alan Green talks markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST on UK Investor Magazine podcast
Alan Green discusses markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST with Jonathan Roy on the UK Investor Magazine podcast.
Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.
Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors
Alan Green talks Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast
Alan Green discusses Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast. Interview is 14 minutes 45 seconds in.
Alan Green presents the investment case for Kavango Resources #KAV and Bidstack #BIDS on his weekly Stockbox Media Research talk
Alan Green presents the investment case for Kavango Resources #KAV and Bidstack #BIDS on his weekly Stockbox Media Research talk
Alan Green talks COVID stocks Novacyt #NCYT), Synairgen #SNG, Avacta #AVCT, plus Blue Prism #PRSM & Capita #CPI on the UK Investor Magazine podcast
The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020.
The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward.
We discuss Novacyt (NCYT), Synairgen (SNG), Avacta (AVCT), Blue Prism (PRSM) and Capita (CPI).
Alan Green talks Mirriad #MIRI, Ixico #IXI, Conroy Gold #CGNR & Keras Resources #KRS on Vox Markets podcast
Alan Green discusses Mirriad #MIRI, Ixico #IXI, Conroy Gold #CGNR & Keras Resources #KRS on Vox Markets podcast. Interview is 9 minutes in.
Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA
Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA
Alan Green talks Keras Resources #KRS, Blencowe Resources #BRES & Cadence Minerals #KDNC on the UK Investor Magazine podcast
Alan Green discusses Keras Resources #KRS, Blencowe Resources #BRES & Cadence Minerals #KDNC with Jonathan Roy on the UK Investor Magazine podcast
